Chad M Robins Adaptive Biotechnologies Corp (ADPT) insider trading activity

ADPT Quotes by TradingView

Chad M Robins is CEO and Chairman of Adaptive Biotechnologies Corp. Currently has a direct ownership of 2.58 Million shares of ADPT, which is worth approximately $9.12 Million. The most recent transaction as insider was on Oct 01, 2020, when has been sold 600 shares (Common Stock) at a price of $50.05 per share, resulting in proceeds of $30,030. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 2.58M
0% 3M change
13.47% 12M change
Total Value Held $9.12 Million

CHAD M ROBINS Transaction History

Date Transaction Value Shares Traded Shares Held Form
Oct 01 2020
SELL
Open market or private sale
$30,030 $50.05 p/Share
600 Reduced 0.03%
1,778,180 Common Stock
Oct 01 2020
BUY
Exercise of conversion of derivative security
$198 $0.33 p/Share
600 Added 0.03%
1,778,780 Common Stock
Sep 29 2020
SELL
Open market or private sale
$95,342 $50.18 p/Share
1,900 Reduced 0.11%
1,778,180 Common Stock
Sep 29 2020
BUY
Exercise of conversion of derivative security
$627 $0.33 p/Share
1,900 Added 0.11%
1,780,080 Common Stock
CMR

Chad M Robins

CEO and Chairman
Seattle, WA

Track Institutional and Insider Activities on ADPT

Follow Adaptive Biotechnologies Corp and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ADPT shares.

Notify only if

Insider Trading

Get notified when an Adaptive Biotechnologies Corp insider buys or sells ADPT shares.

Notify only if

News

Receive news related to Adaptive Biotechnologies Corp

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on ADPT